ViewRay Inc Stock News

The research study presented here is an intelligent take on the global Image Guided Radiation Therapy (IGRT) Market that explains important aspects such as competition, segmentation, and regional growth in great detail. Accuracy and preciseness are two of the key

ADM Tronics Unlimited (OTCMKTS:ADMT) and ViewRay (NASDAQ:VRAY) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations and institutional ownership. Institutional and Insider Ownership 90.6% of ViewRay shares are held by institutional investors. 73.0% of []

Brokerages expect ViewRay, Inc. (NASDAQ:VRAY) to post $20.14 million in sales for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for ViewRays earnings. The highest sales estimate is $21.35 million and the lowest is $19.40 million. ViewRay reported sales of $18.46 million during the same quarter last year, which would []

In the last trading session, 2.58 million shares of the ViewRay Inc. (NASDAQ:VRAY) were traded, and its beta was 0.73. Most recently the company’s share price was $5.58, and it changed around -$0.01 or -0.18% from the last close, which brings the market valuation of the company to $887.05M. VRAY currently trades at a discount … Let’s Talk About How ViewRay Inc. (NASDAQ: VRAY) Stock Is Doing. Read More »

CLEVELAND, Nov. 24, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced, in recognition of Pancreatic Cancer Awareness Month, more than 2,300 pancreatic cancer patients have been treated with MRIdian at 46 centers around the world. ViewRay would like to recognize the global

MetLife Investment Management LLC cut its position in ViewRay, Inc. (NASDAQ:VRAY) by 35.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 32,313 shares of the companys stock after selling 17,969 shares during the quarter. MetLife Investment Management LLCs holdings in ViewRay were []

ViewRay, Inc. (NASDAQ:VRAY) CFO Zachary William Stassen purchased 17,857 shares of the business’s stock in a transaction on Friday, November 19th. The shares were acquired at an average price of $5.60 per share, with a total value of $99,999.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is […]

Related Stocks: VRAY ,

State Street Corp lowered its stake in ViewRay, Inc. (NASDAQ:VRAY) by 11.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,555,441 shares of the companys stock after selling 440,153 shares during the period. State Street Corps holdings in ViewRay were []

According to Market Study Report, Image Guided Radiation Therapy (IGRT) Market provides a comprehensive analysis of the Image Guided Radiation Therapy (IGRT) Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An

Wall Street brokerages expect ViewRay, Inc. (NASDAQ:VRAY) to post earnings per share of ($0.16) for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for ViewRays earnings, with the highest EPS estimate coming in at ($0.14) and the lowest estimate coming in at ($0.20). ViewRay reported earnings of ($0.18) per share in []

Northern Trust Corp increased its holdings in shares of ViewRay, Inc. (NASDAQ:VRAY) by 12.0% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,420,549 shares of the companys stock after acquiring an additional 152,374 shares during the period. Northern Trust Corps holdings in ViewRay were worth $9,376,000 at the end of the most recent reporting []

ViewRay, Inc.'s (VRAY) CEO Scott Drake on Q3 2021 Results - Earnings Call Transcript